{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Catatonie : Questions médicales les plus fréquentes",
"headline": "Catatonie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Catatonie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-23",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Catatonie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Manifestations neurocomportementales",
"url": "https://questionsmedicales.fr/mesh/D019954",
"about": {
"@type": "MedicalCondition",
"name": "Manifestations neurocomportementales",
"code": {
"@type": "MedicalCode",
"code": "D019954",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Catatonie",
"alternateName": "Catatonia",
"code": {
"@type": "MedicalCode",
"code": "D002389",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jonathan P Rogers",
"url": "https://questionsmedicales.fr/author/Jonathan%20P%20Rogers",
"affiliation": {
"@type": "Organization",
"name": "Division of Psychiatry, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Dusan Hirjak",
"url": "https://questionsmedicales.fr/author/Dusan%20Hirjak",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. dusan.hirjak@zi-mannheim.de."
}
},
{
"@type": "Person",
"name": "Michael S Zandi",
"url": "https://questionsmedicales.fr/author/Michael%20S%20Zandi",
"affiliation": {
"@type": "Organization",
"name": "National Hospital for Neurology and Neurosurgery, London, UK, and honorary associate professor, Queen Square Institute of Neurology, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Anthony S David",
"url": "https://questionsmedicales.fr/author/Anthony%20S%20David",
"affiliation": {
"@type": "Organization",
"name": "Institute of Mental Health, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Stefan Fritze",
"url": "https://questionsmedicales.fr/author/Stefan%20Fritze",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36173303",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.02567-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10.",
"datePublished": "2024-04-09",
"url": "https://questionsmedicales.fr/article/38603853",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2024.111780"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36371648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/phar.2741"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staphylococcus aureus response and adaptation to vancomycin.",
"datePublished": "2024-06-01",
"url": "https://questionsmedicales.fr/article/39059821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/bs.ampbs.2024.04.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of Multidrug-Resistant Staphylococcus aureus Isolates and Comparison of Methods of Susceptibility to Vancomycin.",
"datePublished": "2022-10-29",
"url": "https://questionsmedicales.fr/article/36308600",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00284-022-03070-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Comportement et mécanismes comportementaux",
"item": "https://questionsmedicales.fr/mesh/D001520"
},
{
"@type": "ListItem",
"position": 3,
"name": "Manifestations neurocomportementales",
"item": "https://questionsmedicales.fr/mesh/D019954"
},
{
"@type": "ListItem",
"position": 4,
"name": "Catatonie",
"item": "https://questionsmedicales.fr/mesh/D002389"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Catatonie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Catatonie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Catatonie",
"description": "Comment diagnostiquer la catatonie ?\nQuels tests sont utilisés pour la catatonie ?\nLa catatonie peut-elle être confondue avec d'autres troubles ?\nQuels critères sont utilisés pour le diagnostic ?\nLa catatonie est-elle toujours liée à des troubles mentaux ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Catatonie",
"description": "Quels sont les symptômes principaux de la catatonie ?\nLa catatonie peut-elle provoquer des comportements étranges ?\nY a-t-il des symptômes émotionnels associés ?\nLa catatonie peut-elle entraîner des troubles de la conscience ?\nLes symptômes de la catatonie sont-ils constants ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Catatonie",
"description": "Peut-on prévenir la catatonie ?\nQuels facteurs de stress peuvent déclencher la catatonie ?\nLa gestion des maladies mentales aide-t-elle à prévenir la catatonie ?\nLes soins de santé mentale préventifs sont-ils efficaces ?\nL'éducation sur la santé mentale peut-elle aider ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Catatonie",
"description": "Quels traitements sont efficaces pour la catatonie ?\nLa psychothérapie est-elle utile pour la catatonie ?\nLes antipsychotiques sont-ils utilisés pour la catatonie ?\nCombien de temps dure le traitement de la catatonie ?\nY a-t-il des traitements non médicamenteux pour la catatonie ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Catatonie",
"description": "Quelles complications peuvent survenir avec la catatonie ?\nLa catatonie peut-elle entraîner des problèmes physiques ?\nY a-t-il des risques de suicide associés à la catatonie ?\nLes complications sont-elles réversibles ?\nLa catatonie peut-elle affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Catatonie",
"description": "Quels sont les facteurs de risque de la catatonie ?\nL'âge influence-t-il le risque de catatonie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress psychologique est-il un facteur de risque ?\nLes maladies neurologiques augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002389?mesh_terms=Vancomycin-Resistant+Staphylococcus+aureus&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la catatonie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'observation des symptômes et l'exclusion d'autres troubles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la catatonie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des évaluations cliniques et parfois des examens d'imagerie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle être confondue avec d'autres troubles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la schizophrénie ou d'autres troubles psychotiques."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'immobilité, l'excitation, et des comportements stéréotypés."
}
},
{
"@type": "Question",
"name": "La catatonie est-elle toujours liée à des troubles mentaux ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle peut aussi être causée par des conditions médicales ou neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la catatonie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'immobilité, l'excitation, et des postures rigides."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle provoquer des comportements étranges ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des comportements tels que des mouvements répétitifs ou des grimaces peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes émotionnels associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme l'anxiété ou la dépression peuvent accompagner la catatonie."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle entraîner des troubles de la conscience ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des altérations de la conscience ou de la perception."
}
},
{
"@type": "Question",
"name": "Les symptômes de la catatonie sont-ils constants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils peuvent fluctuer et varier en intensité selon les individus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la catatonie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un traitement précoce des troubles mentaux peut aider."
}
},
{
"@type": "Question",
"name": "Quels facteurs de stress peuvent déclencher la catatonie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des événements traumatiques ou un stress intense peuvent déclencher des épisodes de catatonie."
}
},
{
"@type": "Question",
"name": "La gestion des maladies mentales aide-t-elle à prévenir la catatonie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne gestion des maladies mentales peut réduire le risque de catatonie."
}
},
{
"@type": "Question",
"name": "Les soins de santé mentale préventifs sont-ils efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins préventifs peuvent diminuer l'incidence des troubles catatoniques."
}
},
{
"@type": "Question",
"name": "L'éducation sur la santé mentale peut-elle aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser les individus aux troubles mentaux peut favoriser une détection précoce."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour la catatonie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les benzodiazépines et l'électroconvulsivothérapie."
}
},
{
"@type": "Question",
"name": "La psychothérapie est-elle utile pour la catatonie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La psychothérapie peut être bénéfique, mais elle est souvent combinée avec des médicaments."
}
},
{
"@type": "Question",
"name": "Les antipsychotiques sont-ils utilisés pour la catatonie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais leur efficacité peut varier et ils ne sont pas toujours recommandés."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement de la catatonie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie selon la gravité et la réponse du patient aux interventions."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux pour la catatonie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des approches comme la thérapie occupationnelle peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la catatonie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections, des thromboses et des troubles nutritionnels."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle entraîner des problèmes physiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'immobilité prolongée peut causer des problèmes physiques comme des escarres."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de suicide associés à la catatonie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent avoir un risque accru de comportements suicidaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "La catatonie peut-elle affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut gravement affecter la qualité de vie des patients et de leurs proches."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la catatonie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles psychiatriques et les traumatismes sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de catatonie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la catatonie est plus fréquente chez les jeunes adultes et les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de troubles mentaux peut augmenter le risque de catatonie."
}
},
{
"@type": "Question",
"name": "Le stress psychologique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress psychologique intense peut déclencher des épisodes de catatonie."
}
},
{
"@type": "Question",
"name": "Les maladies neurologiques augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies neurologiques peuvent prédisposer à la catatonie."
}
}
]
}
]
}
Resistance to antibiotics is an increasing problem and necessitates novel antibacterial therapies. The polyketide antibiotics cervimycin A to D are natural products of Streptomyces tendae HKI 0179 wit...
Glycopeptide antibiotic vancomycin is a bactericidal antibiotic available for the infection to Staphylococcus aureus (SA), however, SA has a strong adaptive capacity and thereby acquires resistance to...
16S rRNA sequencing data of control samples and urinary tract infection samples were retrieved from the EMBL-EBI (European Molecular Biology Laboratory - European Bioinformatics Institute) database. C...
Gut flora and its species abundance had significant difference between urinary tract infection and control samples. SA was significantly differentially expressed in urinary tract infection samples. Re...
SA upregulates the expression of CXCL10 in urethral epithelial cells, thereby activating the TLR signaling pathway and promoting resistance to glycopeptide antibiotics in SA....
The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus...
Single-center, retrospective cohort study between January 1, 2016, and December 31, 2021....
State University of New York Upstate University Hospital, a 748-bed tertiary care, academic medical center in Syracuse, NY....
Adult patients were included if they had blood cultures positive for MRSA ≥72 h, received vancomycin monotherapy initially, and received vancomycin plus ceftaroline for ≥24 h. Patients were excluded i...
Patients were medically complex with a median Pitt bacteremia score of 3, 63.3% (19/30) were admitted to the intensive care unit, and 66.7% (20/30) had infective endocarditis. Vancomycin-associated ac...
Vancomycin plus ceftaroline may represent an effective and well-tolerated salvage regimen option for persistent MRSAB....
Antibiotic resistance is an increasing challenge for the human pathogen Staphylococcus aureus. Methicillin-resistant S. aureus (MRSA) clones have spread globally, and a growing number display decrease...
S. aureus are among the main bacteria causing problems related to multidrug resistance in nosocomial infections. Therefore, it is necessary to carry out a reliable and rapid diagnosis for the identifi...
This research study was undertaken to investigate antimicrobial resistance patterns and the prevalence of hospital-acquired infections (HAIs). The study focuses on common microorganisms responsible fo...
A comprehensive analysis of 123 patients with HAIs, hospitalized in surgical department and intensive care unit (ICU) at Imam Khomeini Hospital, Ilam, Iran, was conducted over a six-month period. Path...
The study findings revealed a significant prevalence of multidrug-resistant (MDR) isolates, of which 73.3% were MRSA. Notably, 6.7% of S. aureus isolates exhibited resistance to vancomycin, indicating...
This research sheds light on the intricate interplay between drug resistance and HAI, highlighting the imperative role of rational antibiotic use and infection control in addressing this critical heal...
The extension of multidrug-resistant strains of Staphylococcus aureus (S. aureus) is one of the main health challenges in the world, which requires serious solutions to deal with it. Combination thera...
Vancomycin is commonly administered as an intermittent infusion (IIV), although vancomycin's stability at room temperature permits administration continuously over 24 h (CIV). At our institution, CIV ...
This was a retrospective study of patients who received vancomycin for MRSA bacteremia. The primary outcomes were the time to therapeutic goal and frequency of adverse drug reactions on IIV compared t...
Sixty-three patients were included. Significantly fewer patients were able to achieve a therapeutic goal on IIV compared to CIV (52.4% vs. 82.5%, p < 0.01). Patients on IIV took 3.6 days, on average, ...
For MRSA bacteremia, CIV enabled patients to achieve the AUC/MIC goal significantly faster than when patients received IIV. Furthermore, patients who were unable to achieve a therapeutic trough on IIV...
The role of combination therapies for serious methicillin-resistant Staphylococcus aureus (MRSA) infections is widely debated....
This retrospective cohort study included adults with MRSA bacteraemia treated between January 1, 2013, to December 31, 2022. Patients receiving combination therapy with vancomycin and ceftaroline were...
Of 57 patients included, 37 (65%) were in the combination group. The overall intensive care unit admission rate was 63.2% (36/57) and the Pitt Bacteraemia Score was 1 [0-4] at the time of diagnosis. T...
The results of this study are limited by a retrospective observational design; however, combination of vancomycin and ceftaroline for MRSA bacteraemia was not associated with lower bacteraemia recurre...
Staphylococcus aureus are gram-positive bacteria responsible for a wide array of diseases, ranging from skin and soft tissue infections to more chronic illnesses such as toxic shock syndrome, osteomye...